Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Testin is a tumor suppressor and prognostic marker in breast cancer.

Zhu J, Li X, Kong X, Moran MS, Su P, Haffty BG, Yang Q.

Cancer Sci. 2012 Dec;103(12):2092-101. doi: 10.1111/cas.12020. Epub 2012 Oct 22.

2.

Increased N-myc downstream-regulated gene 1 expression is associated with breast atypia-to-carcinoma progression.

Mao XY, Fan CF, Wei J, Liu C, Zheng HC, Yao F, Jin F.

Tumour Biol. 2011 Dec;32(6):1271-6. doi: 10.1007/s13277-011-0232-z. Epub 2011 Sep 10.

PMID:
21909787
3.

Loss of interferon regulatory factor 5 (IRF5) expression in human ductal carcinoma correlates with disease stage and contributes to metastasis.

Bi X, Hameed M, Mirani N, Pimenta EM, Anari J, Barnes BJ.

Breast Cancer Res. 2011;13(6):R111. doi: 10.1186/bcr3053. Epub 2011 Nov 4.

4.

Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients.

Zhao X, Mirza S, Alshareeda A, Zhang Y, Gurumurthy CB, Bele A, Kim JH, Mohibi S, Goswami M, Lele SM, West W, Qiu F, Ellis IO, Rakha EA, Green AR, Band H, Band V.

Breast Cancer Res Treat. 2012 Jul;134(1):171-80. doi: 10.1007/s10549-011-1946-8. Epub 2012 Jan 22.

5.

The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.

Hildenbrand R, Schaaf A.

Int J Oncol. 2009 Jan;34(1):15-23.

PMID:
19082473
6.

Role of deregulated microRNAs in breast cancer progression using FFPE tissue.

Chen L, Li Y, Fu Y, Peng J, Mo MH, Stamatakos M, Teal CB, Brem RF, Stojadinovic A, Grinkemeyer M, McCaffrey TA, Man YG, Fu SW.

PLoS One. 2013;8(1):e54213. doi: 10.1371/journal.pone.0054213. Epub 2013 Jan 23.

7.

Adenoviral transduction of TESTIN gene into breast and uterine cancer cell lines promotes apoptosis and tumor reduction in vivo.

Sarti M, Sevignani C, Calin GA, Aqeilan R, Shimizu M, Pentimalli F, Picchio MC, Godwin A, Rosenberg A, Drusco A, Negrini M, Croce CM.

Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):806-13.

8.
9.

[Loss of fragile histidine triad expression and metastasis in breast cancer].

Zhao P, Li XY, Chen LZ.

Ai Zheng. 2002 Jun;21(6):668-70. Chinese.

PMID:
12452072
10.

TES was epigenetically silenced and suppressed the epithelial-mesenchymal transition in breast cancer.

Yongbin Y, Jinghua L, Zhanxue Z, Aimin Z, Youchao J, Yanhong S, Manjing J.

Tumour Biol. 2014 Nov;35(11):11381-9. doi: 10.1007/s13277-014-2472-1. Epub 2014 Aug 15.

PMID:
25119600
11.

[Expression and significance of hTERT mRNA in breast carcinoma and its relation to p53].

Tang F, Gu DH, Wang H, Zhu TF, Zhu HG, Xu ZD, Hu XQ.

Zhonghua Zhong Liu Za Zhi. 2006 Mar;28(3):192-5. Chinese.

PMID:
16875603
12.

[Expression and prognostic value of transcriptional factor sp1 in breast cancer].

Wang XB, Peng WQ, Yi ZJ, Zhu SL, Gan QH.

Ai Zheng. 2007 Sep;26(9):996-1000. Chinese.

PMID:
17927860
13.

Nek2A contributes to tumorigenic growth and possibly functions as potential therapeutic target for human breast cancer.

Wang S, Li W, Liu N, Zhang F, Liu H, Liu F, Liu J, Zhang T, Niu Y.

J Cell Biochem. 2012 Jun;113(6):1904-14. doi: 10.1002/jcb.24059.

PMID:
22234886
14.

TESTIN suppresses tumor growth and invasion via manipulating cell cycle progression in endometrial carcinoma.

Gu Z, Ding G, Liang K, Zhang H, Guo G, Zhang L, Cui J.

Med Sci Monit. 2014 Jun 14;20:980-7. doi: 10.12659/MSM.890544.

15.

[Detection and clinical significance of Notch1 methylation in breast cancer and intraductal proliferative breast lesions].

Zhang N, Sun ZZ, Li F, Cao YW, Zhao CX, Liang WH, Sun HP, Li HA, Fu XG.

Zhonghua Bing Li Xue Za Zhi. 2011 May;40(5):324-9. Chinese.

PMID:
21756827
16.

The impact of cysteine-rich intestinal protein 1 (CRIP1) in human breast cancer.

Ludyga N, Englert S, Pflieger K, Rauser S, Braselmann H, Walch A, Auer G, Höfler H, Aubele M.

Mol Cancer. 2013 Apr 9;12:28. doi: 10.1186/1476-4598-12-28.

17.

[Promoter methylation and mRNA expression of WT1 gene in MCF10 breast cancer model].

Yang JL, Klinkebiel D, Boland MJ, Tang L, Christman JK.

Zhonghua Bing Li Xue Za Zhi. 2007 Apr;36(4):253-8. Chinese.

PMID:
17706117
18.

Role of MRE11 in cell proliferation, tumor invasion, and DNA repair in breast cancer.

Yuan SS, Hou MF, Hsieh YC, Huang CY, Lee YC, Chen YJ, Lo S.

J Natl Cancer Inst. 2012 Oct 3;104(19):1485-502. doi: 10.1093/jnci/djs355. Epub 2012 Aug 22.

19.

Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.

de Candia P, Akram M, Benezra R, Brogi E.

Hum Pathol. 2006 Aug;37(8):1032-41. Epub 2006 May 22.

PMID:
16867866
20.

Protein kinase C epsilon is a predictive biomarker of aggressive breast cancer and a validated target for RNA interference anticancer therapy.

Pan Q, Bao LW, Kleer CG, Sabel MS, Griffith KA, Teknos TN, Merajver SD.

Cancer Res. 2005 Sep 15;65(18):8366-71.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk